Anonymous
Guest
Anonymous
Guest
I hope everyone realizes that the battle shaping up in the HCV market could not be a better testing ground to illustrate either the success of the NCM, or abject failure of the NCM. It has been quite some time that two companies with very similar agents, with strong medical need were FDA approved into the market within ten days of each other.
This competition will be very telling....David vs Goliath, Big/Slow Pharma vs Lean/Fluid bio tech, I do not need to go on...you get the picture. Will Merck demo launch excellence like the company mandated 2-3 years ago ? Did we place people in positions based on operational and/or market expertise ? Did VPs hire the usual entitled crowd ? Will senior leadership be decapitated if we fail ?
Can't wait to sit back and watch this one....
This competition will be very telling....David vs Goliath, Big/Slow Pharma vs Lean/Fluid bio tech, I do not need to go on...you get the picture. Will Merck demo launch excellence like the company mandated 2-3 years ago ? Did we place people in positions based on operational and/or market expertise ? Did VPs hire the usual entitled crowd ? Will senior leadership be decapitated if we fail ?
Can't wait to sit back and watch this one....